Company News
PCI welcomes Dr Tadataka Yamada to Board of Directors
PCI welcomes Dr Tadataka Yamada to Board of Directors
Formerly Head of R&D at Takeda and GlaxoSmithKline
Dr Ursel Nait joins regulatory specialist Diapharm
Dr Ursel Nait joins regulatory specialist Diapharm
She has been named Senior Manager GMP Services at the German firm
Pharmatech appoints Krystyna Kowalczyk as Chief Operating Officer
Pharmatech appoints Krystyna Kowalczyk as Chief Operating Officer
To further enhance the company's expertise in clinical oncology trials
Mission Therapeutics adds Dr Colin Goddard to its Board of Directors
Mission Therapeutics adds Dr Colin Goddard to its Board of Directors
He was formerly Chief Executive of OSI Pharmaceuticals
Noxxon promotes Aram Mangasarian to Chief Executive
Noxxon promotes Aram Mangasarian to Chief Executive
He has already been at the company for five years as Chief Business Officer
Charlie Barker named Director of Scientific Services at SNBL USA
Charlie Barker named Director of Scientific Services at SNBL USA
He has had wide and varied experience in the toxicology field
Quantitech appoints laser gas analyser specialist
Quantitech appoints laser gas analyser specialist
Craig Day will support the introduction of tuneable diode laser absorption spectroscopy technologies (TDLAS) in UK and Ireland
Sanofi announces new global business unit structure
Sanofi announces new global business unit structure
Establishes three new units for General Medicines & Emerging Markets, Speciality Care and Diabetes & Cardiovascular
New CEO of Avista Pharma Solutions is named
New CEO of Avista Pharma Solutions is named
Patrick Walsh will lead the business which includes Avista Pharma and Accuratus Labs
Zosano Pharma expands clinical and regulatory teams
Zosano Pharma expands clinical and regulatory teams
Appoints three people to executive positions
Two new appointments at Camargo Pharmaceutical Services
Two new appointments at Camargo Pharmaceutical Services
VP, Scientific and Regulatory Affairs and Director, Contracts and Legal Projects
August Faller strengthens its business in Scandinavia
August Faller strengthens its business in Scandinavia
Packaging machinery specialist appoints a new salesperson in Sweden
Total Facility Solutions names new President
Total Facility Solutions names new President
Kurt Gilson is promoted from Vice President and Regional Manager of the Western US and Mexico
Eric Benevich joins Neurocrine Biosciences as Chief Commercial Officer
Eric Benevich joins Neurocrine Biosciences as Chief Commercial Officer
He was most recently Vice President of Marketing at Avanir Pharmaceuticals
Shelonitda Rose to lead clinical programmes at Advaxis
Shelonitda Rose to lead clinical programmes at Advaxis
Joins the US biotechnology company as Vice President, Clinical Development
Mark Bulling appointed Head of Service at Labelling Machines division of HERMA
Mark Bulling appointed Head of Service at Labelling Machines division of HERMA
Also in charge of the new online store www.herma-components.com
Ergomed strengthens management team
Ergomed strengthens management team
Andrew Mackie brings 25 years of industry experience to lead business development at the company
Two new Vice Presidents join Almac Group
Two new Vice Presidents join Almac Group
They will be based in Craigavon, Northern Ireland and Souderton. PA, US
NuCana appoints Professor Chris McGuigan as Chief Scientific Officer
NuCana appoints Professor Chris McGuigan as Chief Scientific Officer
McGuigan was the original inventor of the ProTide technology used in the NuCana Aceleran product
Flamel Technologies makes two new appointments
Flamel Technologies makes two new appointments
SVP of Quality and Regulatory Affairs and VP of Business and Corporate Development join the company
HUYA Bioscience International adds to senior management team
HUYA Bioscience International adds to senior management team
Yoshiki Shimamura joins the company as Vice President for Japan Operations
Dr Gary Ingenito joins Catalyst Pharmaceuticals as Chief Medical Officer
Dr Gary Ingenito joins Catalyst Pharmaceuticals as Chief Medical Officer
He will oversee all clinical development programmes, medical affairs, regulatory and other related functions
UCB scientists embark on 300-mile cycling challenge
UCB scientists embark on 300-mile cycling challenge
To raise money for people with epilepsy in Africa
Catalent makes two key European appointments in oral dose manufacturing
Catalent makes two key European appointments in oral dose manufacturing
New General Managers announced at Schorndorf and Eberbach sites in Germany